SecBot SecBot

SNWV

SANUWAVE Health, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. NV· CIK 0001417663 Healthcare & Medical Devices
$5.07 −0.15 (−2.87%)
Oct 26 4:00 PM ET · prev $5.22
Market cap
$45.6M
Nano cap
Median target
$40.00
+689% · range $40.00–40.00
1 year
−83.7%
from $31.02 · Oct 27
30 days
+9.0%
from $4.65
52-week range
$4.00–35.34
−86% from high · low Sep 10
Avg volume 20D
45.1K
shares / day
Short interest
245.5K
≈2.9% of shares · +2.2%
Days to cover
3.9
at average volume
Insider net
−$2.2M
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read BEARISH 4 reports · 90 days
Balance 3 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 4/4
Strongest BEARISH SANUWAVE Health received a Nasdaq deficiency notice on September 23, 2026, for failing to maintain a Market…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $2.2M.

  • InstitutionsBEARISH

    Q2 2026: 5 added (0 new), 10 trimmed or exited.

  • Short sellersSTEADY

    Short interest +2.2% to 245.5K shares. 3.9 days to cover, ≈2.9% of shares.

  • TrendUPTREND

    6% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.TRIM159,867$1.6M
GEODE CAPITAL MANAGEMENT, LLCTRIM86,098$861.4K
CITADEL ADVISORS LLCDOUBLED59,473$594.7K
JPMORGAN CHASE & CODOUBLED39,697$391.0K
STATE STREET CORPNEAR_EXIT32,282$322.8K
MORGAN STANLEYDOUBLED31,619$316.2K
BANK OF AMERICA CORP /DE/TRIM18,559$185.6K
MILLENNIUM MANAGEMENT LLCTRIM16,925$169.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +689%.Targets as of May 13, 2026.

Recent actions
DateFirmActionRating
Mar 30, 2026Roth Capital
REITERATE
REITERATEBuy
Sep 3, 2025Northland Capital Markets
INITIATE
INITIATEOutperform
Aug 22, 2025Roth Capital
MAINTAIN
MAINTAINBuy
Jul 29, 2025Roth Capital
INITIATE
INITIATEBuy
Sep 15, 2020Lake Street
INITIATE
INITIATEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$2.2M
sold · 1 insider
DateInsiderTypeValue
May 1, 2026
Opaleye Management Inc.
10%+ Owner
SELL$162.4K
May 1, 2026
Opaleye Management Inc.
10%+ Owner
SELL$8.1K
Apr 30, 2026
Opaleye Management Inc.
10%+ Owner
SELL$387.6K
Apr 30, 2026
Opaleye Management Inc.
10%+ Owner
SELL$16.2K
Apr 29, 2026
Opaleye Management Inc.
10%+ Owner
SELL$402.9K
Apr 29, 2026
Opaleye Management Inc.
10%+ Owner
SELL$17.2K
Apr 28, 2026
Opaleye Management Inc.
10%+ Owner
SELL$808.7K
Apr 28, 2026
Opaleye Management Inc.
10%+ Owner
SELL$46.2K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
245,504
shares short
+2.2%
vs prior settlement
3.9
days to cover
≈2.9%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Listing status
Listing Status: SNWV — Deficient (was Normal)
SANUWAVE Health, Inc. - Common Stock | Nasdaq Financial Status Indicator N → D
Sep 25, 2026 SEC
SANUWAVE Health received a Nasdaq deficiency notice on September 23, 2026, for failing to maintain a Market Value of…
8-K — Impact 7/10
Aug 6, 2026 SEC
SANUWAVE reported Q2 2026 revenue of $9.7M, down 3% YoY from $10.1M, swinging to a net loss of $0.7M vs net income of…
8-K — Impact 7/10
Aug 6, 2026 SEC
SANUWAVE Health reported Q2 2026 revenue of $9.7M (down 3% YoY) and a net loss of $0.7M vs net income of $0.6M a year…
PRESS-RELEASE — Impact 7/10
Jun 30, 2026 Inst.
BlackRock, Inc. — TRIM
159,867 shares ($1.6M)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — TRIM
86,098 shares ($861.4K)
May 1, 2026 Insider
Opaleye Management Inc. sold 10,081 shares
10%+ Owner @ $16.11 ($162.4K)
May 1, 2026 Insider
Opaleye Management Inc. sold 500 shares
10%+ Owner @ $16.11 ($8.1K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 30, 2026
Listing
Listing Status: SNWV — Deficient (was Normal)
SANUWAVE Health, Inc. - Common Stock | Nasdaq Financial Status Indicator N → D
Aug 6, 2026
Earnings
Sanuwave Announces Q2 FY2026 Financial Results
Sanuwave Announces Q2 FY2026 Financial Results
Jul 30, 2026
Earnings
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
Jun 16, 2026
Earnings
Sanuwave Health Updates Second Quarter 2026 Guidance
Sanuwave Health Updates Second Quarter 2026 Guidance
May 12, 2026
Earnings
Sanuwave Announces Revenues and Financial Results for Q1 FY2026
Sanuwave Announces Revenues and Financial Results for Q1 FY2026

SecBot reports

11 filings · 2 press releases · 0 bullish · 5 bearish · 1 mixed · 5 neutral
All SNWV filing & press-release reports (13)